RankAlpha logo
Back to Rankings

MRVI

Maravai LifesciencesB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
Current thesis
The bull case is that Q1 was not just a one-time pop: TriLink base non-COVID revenue grew 15.4%, total TriLink revenue grew 65.1%, adjusted EBITDA turned positive at $20.3 million, free cash flow returned positive, and management raised both revenue and EBITDA guidance off the print. That combination supports a cleaner turnaround narrative than the prior filing-monitoring baseline.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +2.1.
What can break
A meaningful portion of Q1 upside came from $14.3 million of high-volume CleanCap orders for commercial COVID vaccine programs, which may not be a durable quarterly run rate. [#8-K-2026-05-07]
Momentum
93
Value
41
Sentiment
38
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.30 · Bull $5.60 · Bear $3.10
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $4.33
Why
Momentum93 · Δ7d +2.1
Value41 · Δ7d +0.1
Sentiment38 · Δ7d -4.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
93
34% active weight
Current posture
7d trendFlat
Δ7d
+2.1
Δ21d
+0.9
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
38
33% active weight
Current posture
7d trendSoftening
Δ7d
-4.5
Δ21d
+7.1
Why this grade

Composite grade B. Momentum 92.9 / Value 41.1 / Sentiment 38.1

Fundamentals (TTM)
As of 2026-06-01
Market Cap
$1.23B
Beta
0.38
Shares Out
255.71M
P/E (TTM) · Derived
-5.3
P/S (TTM)
5.04
P/FCF (TTM) · Derived
-10.30
Rev YoY
-39.7%
EPS YoY
+74.2%
Gross Margin
+20.9%
Op Margin
-102.9%
Net Debt
$5.43M
Current Ratio
5.29
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology